Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSAPREPITANT DIMEGLUMINE vs FOSCARNET: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FOSAPREPITANT DIMEGLUMINE vs FOSCARNET: Safety Overview

Metric FOSAPREPITANT DIMEGLUMINE FOSCARNET
Total FAERS Reports 888 2,057
Deaths Reported 118 605
Death Rate 13.3% 29.4%
Hospitalizations 364 608
Average Patient Age 57.0 yrs 41.8 yrs
% Female Patients 50.1% 40.6%
FDA Approval Date Aug 20, 2020 Apr 21, 2021
Manufacturer Dr. Reddy's Laboratories Inc., Hikma Pharmaceuticals USA Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status Discontinued Prescription